2.10
price up icon3.96%   0.08
pre-market  시장 영업 전:  2.09   -0.01   -0.48%
loading
전일 마감가:
$2.02
열려 있는:
$2.03
하루 거래량:
536.53K
Relative Volume:
0.60
시가총액:
$223.47M
수익:
$45.44M
순이익/손실:
$-35.43M
주가수익비율:
-6.1765
EPS:
-0.34
순현금흐름:
$-25.39M
1주 성능:
-6.25%
1개월 성능:
+2.94%
6개월 성능:
-58.82%
1년 성능:
-52.27%
1일 변동 폭
Value
$2.02
$2.14
1주일 범위
Value
$2.02
$2.28
52주 변동 폭
Value
$2.00
$5.20

맥스사이트 Stock (MXCT) Company Profile

Name
명칭
Maxcyte Inc
Name
전화
301-517-5556
Name
주소
9713 KEY WEST AVENUE,, ROCKVILLE
Name
직원
114
Name
트위터
Name
다음 수익 날짜
2025-03-11
Name
최신 SEC 제출 서류
Name
MXCT's Discussions on Twitter

MXCT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
MXCT
Maxcyte Inc
2.10 238.15M 45.44M -35.43M -25.39M -0.34
Medical Devices icon
ABT
Abbott Laboratories
124.42 229.71B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
103.78 154.35B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
387.32 149.60B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
89.70 114.97B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.56 45.92B 5.54B 4.18B 623.10M 7.00

맥스사이트 Stock (MXCT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-11-29 개시 Craig Hallum Buy
2021-10-15 재개 Cowen Outperform
2021-08-24 개시 BTIG Research Buy
2021-08-24 개시 Cowen Outperform
2021-08-24 개시 Stephens Overweight
2021-08-24 개시 Stifel Buy
2021-08-24 개시 Wedbush Outperform
2021-08-24 개시 William Blair Outperform
모두보기

맥스사이트 주식(MXCT)의 최신 뉴스

pulisher
Jul 21, 2025

What analysts say about MaxCyte Inc. stockExceptional profit potential - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Is MaxCyte Inc. a good long term investmentExceptional market positioning - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What drives MaxCyte Inc. stock priceRapid growth trajectories - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

MaxCyte Inc. Stock Analysis and ForecastSuperior portfolio returns - Autocar Professional

Jul 20, 2025
pulisher
Jul 15, 2025

Why MaxCyte Inc. stock attracts strong analyst attentionHigh Potential Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes MaxCyte Inc. stock price move sharplySwing Trade Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

IWN ETF Implied Analyst Target Price: $198.15 - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

How MaxCyte Inc. stock performs during market volatilityDaily Swing Candidates - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - The Manila Times

Jul 09, 2025
pulisher
Jul 09, 2025

MaxCyte, Inc. to Release Second Quarter 2025 Financial Results on August 6th - Nasdaq

Jul 09, 2025
pulisher
Jul 02, 2025

PHC announces exclusive distribution of MaxCyte ExPERT platform in Japan - BioSpectrum Asia

Jul 02, 2025
pulisher
Jul 01, 2025

PHC TO EXCLUSIVELY DISTRIBUTE MAXCYTE CELL ENGINEERING PLATFORM IN JAPAN - bernama

Jul 01, 2025
pulisher
Jul 01, 2025

Business Wire - JIJI PRESS

Jul 01, 2025
pulisher
Jul 01, 2025

PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan - Business Wire

Jul 01, 2025
pulisher
Jun 26, 2025

MaxCyte Cancels AIM Market Trading for Common Stock - TipRanks

Jun 26, 2025
pulisher
Jun 25, 2025

MaxCyte shares trading for last time in London - Sharecast.com

Jun 25, 2025
pulisher
Jun 23, 2025

Moving Gene Editing Advances Into the Clinic - the-scientist.com

Jun 23, 2025
pulisher
Jun 19, 2025

MaxCyte shareholders approve equity plan expansion, AIM delisting By Investing.com - Investing.com India

Jun 19, 2025
pulisher
Jun 18, 2025

MaxCyte Shareholders Approve Equity Plan Amendment - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

MaxCyte shareholders approve equity plan expansion, AIM delisting - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Analyzing Ratios: MaxCyte Inc (MXCT)’s Financial Story Unveiled - DWinneX

Jun 18, 2025
pulisher
Jun 13, 2025

California State Teachers Retirement System Sells 82,134 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

MaxCyte Announces Change in Major Holdings by BlackRock - TipRanks

Jun 12, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte & Ori Biotech Integrate Platforms for Efficient Manufacturing - Contract Pharma

Jun 11, 2025
pulisher
Jun 11, 2025

Market news - investments.halifax.co.uk

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte enters collaboration with Ori Biotech - Sharecast.com

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte (MXCT) Partners with Ori Biotech to Boost Cell Therapy Manufacturing | MXCT Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech Forge Strategic Partnership to Enhance Cell Therapy Manufacturing Efficiency - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech Join Forces to Transform CAR-T Cell Production Timeline and Efficiency - Stock Titan

Jun 11, 2025
pulisher
Jun 10, 2025

MaxCyte and Ori Biotech Collaborate to Enhance Cell Therapy Manufacturing - TipRanks

Jun 10, 2025
pulisher
Jun 09, 2025

Kalkine: NASDAQ Today Sees Movement in MaxCyte Amid Sector-Wide Shifts - Kalkine Media

Jun 09, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Decreases Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Purchases Shares of 17,800 MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

MaxCyte (NASDAQ:MXCT) Rating Increased to Hold at Wall Street Zen - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

MaxCyte Announces Change in Voting Rights Structure - TipRanks

Jun 06, 2025
pulisher
Jun 05, 2025

BlackRock Increases Stake in MaxCyte to 9.98% - TipRanks

Jun 05, 2025

맥스사이트 (MXCT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

맥스사이트 주식 (MXCT) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Soleymannezhad Ali
Chief Commercial Officer
Mar 18 '25
Sale
3.18
1,211
3,850
59,439
Sandoval David I.
GENERAL COUNSEL
Mar 18 '25
Sale
3.18
353
1,122
64,219
Swirsky Douglas J
CHIEF FINANCIAL OFFICER
Mar 18 '25
Sale
3.18
6,939
22,061
111,811
Johnston John Joseph
Director
Jan 27 '25
Option Exercise
2.93
3,000
8,796
144,950
Johnston John Joseph
Director
Jan 27 '25
Sale
4.64
3,000
13,935
141,950
Sandoval David I.
GENERAL COUNSEL
Jan 13 '25
Sale
4.54
4,466
20,272
41,447
Johnston John Joseph
Director
Dec 26 '24
Option Exercise
2.93
3,000
8,796
144,950
Johnston John Joseph
Director
Dec 26 '24
Sale
4.01
3,000
12,021
141,950
$280.96
price down icon 1.15%
medical_devices STE
$222.65
price down icon 1.30%
medical_devices PHG
$24.54
price down icon 0.24%
$84.03
price up icon 0.17%
$74.16
price down icon 2.37%
medical_devices EW
$76.56
price up icon 0.09%
자본화:     |  볼륨(24시간):